The O'Reilly Factor | The X Factor (UK) | Microphthalmia-associated transcription factor | The X Factor | Fear Factor | receptor | Max Factor | LDL receptor | Receptor (biochemistry) | The X Factor (TV series) | Continuous erythropoietin receptor activator | B-cell activating factor | GABA receptor | Epidermal growth factor receptor | Psi Factor: Chronicles of the Paranormal | NMDA receptor | Astro Boy: Omega Factor | The Limits to Growth | Sensory receptor | receptor (biochemistry) | metabotropic glutamate receptor | growth | Economic growth | 5-HT2A receptor | VLDL receptor | twist transcription factor | The X Factor (U.S.) | The X Factor (UK TV series) | The X Factor (UK series 2) | The Omega Factor |
Pegdinetanib (USAN; planned trade name Angiocept) is an investigational anti-cancer drug that acts as a selective antagonist of vascular endothelial growth factor receptor 2 (VEGFR-2), hindering vascularization of tumors.